Young women with BRCA1 mutation 'should remove ovaries earlier'
2/25/2014
It is widely known that having a BRCA1 gene mutation increases risk of female breast and ovarian cancers. And now, findings from a large international study suggest that women with these mutations should have preventive surgery to remove the ovaries by the age of 35, rather than waiting until a later age when the risk of ovarian cancer greatly increases.
Young women with BRCA1 mutation 'should remove ovaries earlier'
2/25/2014
It is widely known that having a BRCA1 gene mutation increases risk of female breast and ovarian cancers. And now, findings from a large international study suggest that women with these mutations should have preventive surgery to remove the ovaries by the age of 35, rather than waiting until a later age when the risk of ovarian cancer greatly increases.
Cheap urine test for cancer steps closer
2/25/2014
Non-infectious illnesses like cancer and cardiovascular diseases are rising globally, but they are hard to diagnose because of lack of biomarkers, and in countries with poor infrastructure, expensive diagnosis using mammograms and colonoscopy is not available to many.
Salt imbalance occurs in nearly a third of hospitalised patients
2/25/2014
Simple guidelines for diagnosing and treating a salt imbalance occurring in up to 30% of hospitalised patients are published in the European Journal of Endocrinology. The guidelines recommend that any hospital-based clinician must be able to correctly diagnose, classify and treat hyponatraemia, which is associated with morbidity, mortality and length of hospital stay in a wide range of conditions.
Cheap urine test for cancer steps closer
2/25/2014
Non-infectious illnesses like cancer and cardiovascular diseases are rising globally, but they are hard to diagnose because of lack of biomarkers, and in countries with poor infrastructure, expensive diagnosis using mammograms and colonoscopy is not available to many.
Salt imbalance occurs in nearly a third of hospitalised patients
2/25/2014
Simple guidelines for diagnosing and treating a salt imbalance occurring in up to 30% of hospitalised patients are published in the European Journal of Endocrinology. The guidelines recommend that any hospital-based clinician must be able to correctly diagnose, classify and treat hyponatraemia, which is associated with morbidity, mortality and length of hospital stay in a wide range of conditions.
Experimental treatment eradicates acute leukemia in mice
2/25/2014
A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.The study, led by Dr.
Cancer patients want more written information on late effects
2/25/2014
Patients who undergo radiotherapy for pelvic cancers want to be better informed about side effects before treatment, research has revealed.Half of patients who took part in a UK survey reported unmet information needs on a range of issues, including rehabilitation, ways to access supportive services and how to cope with the treatment's sexual consequences.
Experimental treatment eradicates acute leukemia in mice
2/25/2014
A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.The study, led by Dr.
Now indication and hint of major added benefit for patients with metastatic prostate cancerEnzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.